EGF and ovarian cancer: EGF secreted by M2-like TAMs may inhibit the expression of metastasis-inhibiting LIMT (lncRNA inhibiting metastasis) by activating the EGFR-ERK pathway to stimulate tumor progression in ovarian cancers (75).